Sodium/Potassium-ATPase β1 Activators encompass a range of chemical compounds that, through various mechanisms, indirectly enhance the functional activity of Sodium/Potassium-ATPase β1, a crucial ion pump in maintaining cellular electrolyte balance. Compounds such as Ouabain and Digoxin exert their effects by initially inhibiting the Na⁺/K⁺-ATPase pump, leading to increased intracellular sodium levels. This perturbation prompts a compensatory response, enhancing the activity of Sodium/Potassium-ATPase β1 to restore ion equilibrium. Similarly, hormones and neurotransmitters like Angiotensin II, Dopamine, Norepinephrine, and Endothelin-1, through their respective receptor-mediated signaling pathways, indirectly influence Sodium/Potassium-ATPase β1. These interactions are integral to the regulation of cardiovascular and renal functions, demonstrating how systemic physiological signals can modulate the activity of this vital ion pump. Additionally, Adenosine and Prostaglandin E2, through their receptor-mediated effects, contribute to the modulation of Sodium/Potassium-ATPase β1 in the context of cardiac function and inflammatory responses, respectively.
The activity of Sodium/Potassium-ATPase β1 is further influenced by metabolic and signaling molecules like Catecholamine, Insulin, Aldosterone, and Nitric Oxide. Catecholamine, through its impact on cAMP levels, indirectly modulates the ion pump's activity, linking adrenergic signaling to ion homeostasis. Insulin and Aldosterone play pivotal roles in electrolyte transport and balance, thereby enhancing the function of Sodium/Potassium-ATPase β1 in response to metabolic and mineralocorticoid signals. Nitric Oxide, a key regulator in vascular smooth muscle cells, also indirectly influences the activity of Sodium/Potassium-ATPase β1, underlying its role in blood pressure regulation. Collectively, these activators, through their targeted effects on various biochemical pathways and cellular processes, facilitate the enhancement of Sodium/Potassium-ATPase β1 activity, crucial for maintaining cellular ion balance and physiological homeostasis.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Ouabain-d3 (Major) | sc-478417 | 1 mg | $516.00 | |||
Ouabain specifically inhibits Na⁺/K⁺-ATPase pump, leading to elevated intracellular sodium. This triggers compensatory mechanisms, indirectly enhancing Sodium/Potassium-ATPase β1 activity to re-establish ion homeostasis. | ||||||
12β-Hydroxydigitoxin | 20830-75-5 | sc-213604 sc-213604A | 1 g 5 g | $143.00 $694.00 | ||
12β-Hydroxydigitoxin binds and inhibits the Na⁺/K⁺-ATPase pump, causing increased intracellular Na⁺ levels. This indirectly stimulates Sodium/Potassium-ATPase β1 to maintain electrolyte balance. | ||||||
Catechin | 154-23-4 | sc-205624 sc-205624A | 1 mg 5 mg | $133.00 $299.00 | 3 | |
Catecholamine, via adrenergic receptors, influences cAMP levels, which subsequently modulates Sodium/Potassium-ATPase β1 activity, linking adrenergic signaling to ion pump regulation. | ||||||
Adenosine | 58-61-7 | sc-291838 sc-291838A sc-291838B sc-291838C sc-291838D sc-291838E sc-291838F | 1 g 5 g 100 g 250 g 1 kg 5 kg 10 kg | $34.00 $48.00 $300.00 $572.00 $1040.00 $2601.00 $4682.00 | 1 | |
Adenosine binds to its receptors, affecting intracellular signaling that indirectly enhances Sodium/Potassium-ATPase β1, particularly in cardiac function modulation. | ||||||
Dopamine | 51-61-6 | sc-507336 | 1 g | $290.00 | ||
Dopamine, through dopamine receptor interaction, indirectly influences Sodium/Potassium-ATPase β1 activity, playing a role in cardiovascular and renal functions. | ||||||
Aldosterone | 52-39-1 | sc-210774 sc-210774A sc-210774B sc-210774C sc-210774D sc-210774E | 2 mg 5 mg 10 mg 50 mg 100 mg 250 mg | $259.00 $213.00 $317.00 $1550.00 $3074.00 $7637.00 | 1 | |
Aldosterone enhances Sodium/Potassium-ATPase β1 activity by altering electrolyte transport, primarily in kidney cells, as part of mineralocorticoid regulation. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Insulin indirectly activates Sodium/Potassium-ATPase β1 through its effects on cellular glucose and electrolyte metabolism, affecting ion pump function. | ||||||
PGE2 | 363-24-6 | sc-201225 sc-201225C sc-201225A sc-201225B | 1 mg 5 mg 10 mg 50 mg | $57.00 $159.00 $275.00 $678.00 | 37 | |
Prostaglandin E2 modulates Sodium/Potassium-ATPase β1 activity by binding to its receptors, playing a role in inflammation and electrolyte balance. | ||||||
L-Noradrenaline | 51-41-2 | sc-357366 sc-357366A | 1 g 5 g | $326.00 $485.00 | 3 | |
Norepinephrine enhances Sodium/Potassium-ATPase β1 activity through adrenergic receptors, contributing to cardiovascular regulation and stress response mechanisms. | ||||||